Parnax Lab has informed that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 , to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter ended 31st December, 2021 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015; Any other business with the permission of the chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director.
The above information is a part of company’s filings submitted to BSE.
